Different Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide between Patients with Choroidal and Retinal Neovascularization
Authors:
- Fenq-Lih LeeFLFenq-Lih Lee
- Wen-Ming HsuWHWen-Ming Hsu
- Shih-Jen ChenSCShih-Jen Chen
- 1 June 2006
- journal article
- research article
- Published by S. Karger AG in Ophthalmologica
- Vol. 220 (4) , 246-251
Abstract
Because the blood flow is much more intense in the choroid than in the retina, it is interesting to explore whether choroidal neovascularization (CNV) is more influenced by plasma angiogenic factors than retinal neovascularization. The aim of this study was to investigate plasma profiles of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients with CNV due to age-related macular degeneration (AMD) and in those with retinal neovascularization due to proliferative diabetic retinopathy (PDR). Seventy-seven subjects with AMD, 22 with PDR, and 42 nondiabetic, non-AMD controls were enrolled in this comparative case series. AMD subjects were classified into three groups: dry type (dry AMD, n = 17), wet type with active CNV (CNV/AMD, n = 42), and disciform scar due to advanced wet AMD (scar/AMD, n = 18). Plasma VEGF and NO levels of each subject were measured with enzyme-linked immunosorbent assay and chemiluminescence, respectively. Plasma VEGF level in CNV/AMD (median 256.0 pg/ml, interquartile range 146.4–375.3 pg/ml) was significantly higher than in PDR (124.8 pg/ml, 75.7–215.3 pg/ml; p = 0.004) and controls (120.3 pg/ml, 82.8–168.2 pg/ml, p =0.001). CNV/AMD also had the highest VEGF level among the AMD subgroups. Plasma NO level was significantly elevated in PDR (137.4 µM, 63.7–240.1 µM) when compared with CNV/AMD (71.8 µM, 42.4–113.3 µM; p = 0.004) and controls (62.6 µM, 39.0–114.9 µM; p = 0.002). There was no significant difference in NO levels among the AMD subgroups. No significant correlation between VEGF and NO levels was noted. These findings indicate that both circulating VEGF and NO may play different roles in the pathogenesis of retinal neovascularization and CNV.Keywords
This publication has 24 references indexed in Scilit:
- Interleukin-8, Nitric Oxide and Glutathione Status in Proliferative Vitreoretinopathy and Proliferative Diabetic RetinopathyOphthalmic Research, 2003
- Possible Involvement of Nitric Oxide in the Progression of Diabetic RetinopathyOphthalmologica, 2003
- Detection of Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Choroidal Neovascular MembranesOphthalmologica, 2002
- Nitric oxide is proangiogenic in the retina and choroid*Journal of Cellular Physiology, 2002
- Direct Measurement of VEGF-Induced Nitric Oxide Production by Choroidal Endothelial CellsMicrovascular Research, 2001
- Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathyAmerican Journal of Ophthalmology, 2000
- Polarized Vascular Endothelial Growth Factor Secretion by Human Retinal Pigment Epithelium and Localization of Vascular Endothelial Growth Factor Receptors on the Inner ChoriocapillarisThe American Journal of Pathology, 1999
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997
- Biochemistry of Nitric Oxide and Its Redox-Activated FormsScience, 1992
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992